Marc Larkins

Johnson & Johnson

Assets Managed

$652.356M

Holdings

Last Quarter

2026 - Q1

Filed Date

1mo 2d ago

Growth Rate

17.54%(2Q avg: 13.84%)

Sustained Growth

3 quarters

Portfolio positions

This chart displays the top 10 holdings in Johnson & Johnson's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 16 positions.

Assets under management

The assets under management (AUM) of Johnson & Johnson over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 652.356M in assets, with a quarterly growth rate of 17.54% and a 2-quarter average growth rate of 13.84%. The portfolio is managed by Marc Larkins, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value
PTGX Protagonist Therapeutics Inc Recent Activity	39.58%	$258.144M 2.449M shares@ $105.4 avg price
NBTX Nanobiotix Sa - Adr Recent Activity	26.62%	$173.607M 5.624M shares@ $30.88 avg price
MGTX Meiragtx Holdings Plc Recent Activity	8.82%	$57.512M 6.641M shares@ $8.66 avg price
RAPP Rapport Therapeutics Inc Recent Activity	8.56%	$55.838M 1.785M shares@ $31.3 avg price
CVRX Cvrx Inc Recent Activity	5.84%	$38.075M 4.025M shares@ $9.46 avg price
CTNM Contineum Therapeutics Inc-a Recent Activity	3.97%	$25.848M 1.979M shares@ $13.06 avg price
LEGN Legend Biotech Corp-adr Recent Activity	2.26%	$14.736M 814,586 shares@ $18.1 avg price
XNCR Xencor Inc Recent Activity	1.39%	$9.022M 748,062 shares@ $12.07 avg price
PRCT Procept Biorobotics Corp Recent Activity	1.38%	$8.952M 357,939 shares@ $25.01 avg price
FATE Fate Therapeutics Inc Recent Activity	0.63%	$4.055M 3.379M shares@ $1.21 avg price

1-10 of 16